Press Releases

Please click here if you wish to receive an e-mail notification regarding Alector press releases.

Jan 31, 2020
Alector Announces Full Exercise of Underwriters' Option to Purchase Additional Shares in Public Offering
Jan 28, 2020
Alector Announces Initiation of Phase 1b Study of AL003 in Alzheimer’s Disease Patients
Jan 06, 2020
Alector Initiates First-in-Human Dosing in Phase 1 Study of AL101 for the Treatment of Neurodegenerative Diseases
Displaying 11 - 16 of 16